Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort

In Germany, Tocilizumab (TCZ) is used for the treatment of rheumatoid arthritis both in biologic-naïve patients and those with previous failures of biologic disease-modifying antirheumatic drugs (bDMARDs). The long-term effectiveness and retention rates of TCZ in patients with different numbers of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Baganz, Lisa, Richter, Adrian, Kekow, Jörn, Bussmann, Arnold, Krause, Andreas, Stille, Carsten, Listing, Joachim, Zink, Angela, Strangfeld, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Cohort Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854739/
https://www.ncbi.nlm.nih.gov/pubmed/29143933
http://dx.doi.org/10.1007/s00296-017-3870-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854739/
https://www.ncbi.nlm.nih.gov/pubmed/29143933
http://dx.doi.org/10.1007/s00296-017-3870-7

Ejemplares similares